CJC-1295 DAC Protocol
Dosing & Research
Last Updated: April 22, 2026
Long-acting GH secretagogue research, IGF-1 elevation studies, Body-composition models, Recovery protocols
Half-Life
6-8 days
Administration
Subcutaneous
Frequency
Once Or Twice Weekly
How It Works
- Long-acting GH secretagogue research
- IGF-1 elevation studies
- Body-composition models
- Recovery protocols
Dosing Structure
Dose
1–2mg per week (once or twice weekly)
Frequency
Once Or Twice Weekly
Notes
1–2mg per week, administered once or twice weekly. Do not use daily — the DAC (Drug Affinity Complex) provides a prolonged release window that makes daily dosing unnecessary and counterproductive. Inject: Abdomen (preferred), outer thigh, deltoid area. Break: 4-8 weeks mandatory to allow receptor recovery period.
Example Protocols
Dose: 1–2mg per week (once or twice weekly)
Frequency: Once Or Twice Weekly
Duration: 8-12 weeks; minimum 4-8 weeks break
Off Period: Not listed
Protocol Notes
•
1–2mg per week, administered once or twice weekly.
•
Do not use daily — the DAC (Drug Affinity Complex) provides a prolonged release window that makes daily dosing unnecessary and counterproductive.
•
Inject: Abdomen (preferred), outer thigh, deltoid area.
•
Break: 4-8 weeks mandatory to allow receptor recovery period.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.